New way to control protein activity could lead to cancer therapies

September 29, 2008

STANFORD, Calif. - Investigators at the Stanford University School of Medicine have found a way to quickly and reversibly fine-tune the activity of individual proteins in cells and living mammals, providing a powerful new laboratory tool for identifying - more precisely than ever before - the functions of different proteins.

The new technique also could help to speed the development of therapies in which cancer-fighting proteins are selectively delivered to tumors.

The procedure, described in a Nature Medicine paper to be published online Sept. 28, appears to be broadly applicable to efforts to understand the biological roles of all kinds of proteins, including those that are secreted by cells. This category includes many potent intercellular signaling proteins that can influence the immune system, for example by attracting its attention to an existing tumor.

"We have yet to find a protein the system doesn't work with," said senior author Steve Thorne, PhD, an assistant professor at the University of Pittsburgh who was involved in the work while a research associate at Stanford. The work was conducted under the direction of Chris Contag, PhD, associate professor of pediatrics, of radiology and of microbiology and immunology; and Tom Wandless, PhD, assistant professor of chemical and systems biology.

This technique, which was tested in mice, involves pairing specially bioengineered proteins with a drug, aptly named Shield-1, that prevents the proteins from being degraded.

This approach stands in contrast to current ways of learning about proteins' functions, which are largely based on impeding a cell's production of the protein. Unfortunately, that cellular process can be slow and cumbersome, meaning that scientists get a sluggish response to such manipulations. In addition, current methods to perturb protein function are either irreversible - once a protein's production is knocked out, it can't be turned back on - or difficult to execute.

The new technique, instead, influences the level of speed with which the protein is broken down-a much faster process than its production. Moreover, it is reversible and works like a dimmer switch for an overhead light. The rate of a protein's degradation - and, thus, the level of its biological activity - can be increased or decreased by supplying more or less of Shield-1, permitting scientists to study the biological effects of slightly increasing or diminishing a protein's activity inside a cell over short time frames: for example, during a particular period in an organism's development.

The Stanford team succeeded in controlling levels of proteins by a relatively simple method pioneered by Wandless and his then-graduate student, Laura Banaszynski, PhD. They created special, bioengineered versions of several different proteins, in each case altering the protein by adding a small extra piece that didn't interfere with its biological function, but flagged it for rapid degradation. This degradation can be halted in its tracks, however, by Shield-1, which binds to the bioengineered protein, shielding it from destruction by the cell's breakdown machinery. The drug thus can enhance the bioengineered protein's intracellular concentration and activity; withdrawing the drug has the opposite effect.

"The process is tunable, and fast. As soon as you remove the drug, you affect the degradation time of the protein," said Mark Sellmyer, a graduate student at the School of Medicine, who shares lead authorship of the study with Banaszynski.

The degradation-vulnerable bioengineered proteins were each produced by attaching the gene coding for a protein to another DNA sequence coding for the small extra piece that flags the protein for rapid degradation. The scientists then inserted the altered gene into a virus capable of infecting cells and introducing the altered gene into the cells' genomes.

In experiments demonstrating for the first time that the new technique can be used to effectively regulate a physiologically active protein in live mice, cultured tumor cells were grafted under the skin of immunologically impaired mice. As expected, the mice developed numerous tumors. The investigators had altered these cultured tumor cells so that they produced a degradation-prone bioengineered version of the protein IL-2 that, when secreted by cells, sends potent signals drawing the immune system's attention to those cells. When these altered tumor cells were grafted subcutaneously in the absence of Shield-1, the tumors grew just as before.

But if the tumor cells were first pretreated with Shield-1 they secreted IL-2, preventing any initial tumor growth. If Shield-1 was withheld at first and then administered to the mice five days after the grafts, tumors that had developed in those first few days regressed. By day 14, the tumors were gone.

Another set of experiments employed a mutant virus that had been previously developed by Thorne as a cancer therapy. The investigators inserted the gene for a bioengineered, degradation-prone form of a cell-killing protein into the specialized virus. They then administered it intravenously to live, tumor-bearing mice. When no Shield-1 was provided, the tumor growth was only slightly diminished. But if Shield-1 was supplied three days after infection, when the virus had established a solid foothold in the tumors but been cleared from normal cells, tumors were completely eradicated in 90 percent of the mice. Meanwhile, normal cells were spared the substance's lethal effects.

Stanford University Medical Center

---

---

	Signals and Systems for Bioengineers, Second Edition: A MATLAB-Based Introduction (Biomedical Engineering) by John Semmlow (Author) This book guides the reader through the electrical engineering principles that can be applied to biological systems and are therefore important to biomedical studies. The basic engineering concepts that underlie biomedical systems, medical devices, biocontrol, and biosignal analysis are explained in detail. This textbook is perfect for the one-semester bioengineering course usually offered in conjunction with a laboratory on signals and measurements which presents the fundamentals of systems and signal analysis. The target course occupies a pivotal position in the bioengineering curriculum and will play a critical role in the future development of bioengineering students. There are extensive questions and problems that are available through a companion site to enhance the learning...
	Circuits, Signals, and Systems for Bioengineers: A MATLAB-Based Introduction (Biomedical Engineering) by John Semmlow (Author) Approaches such as the Transfer Function and the Fourier and the Laplace transforms are important tools for bioengineers that often considered borrowed from electrical engineering. This text allows bioengineering students and bioengineers the ability to foster a sense of ownership of these tools by providing them with a solid foundation in the concepts of linear systems analysis. Circuits, Signals and Systems for Bioengineers guides readers through the basic engineering concepts that underlie biological systems, medical devices, biocontrol, and biosignal analysis. Material important to their study and traditionally taught in an electrical engineering service course can now be embraced by bioengineers. To further enhance the effectiveness of the book, instructive illustrations...
	Biologically-responsive Hybrid Biomaterials: A Reference for Material Scientists and Bioengineers by Jabbari Esmaiel (Author) Conjugation of synthetic materials with cell-responsive biologically-active molecules, in addition to providing structural support and release of biomolecules in the regenerating region, can provide the signaling factors required to initiate the cascade of cell migration, adhesion, differentiation, maturation, growth factor modulation, maintenance of matrix integrity, and tissue morphogenesis. Nanoparticles conjugated with ligands that preferentially interact with cell surface receptors in the tumor environment have the potential to drastically improve bioavailability, selectivity and residence time of the chemotherapeutic agent in the tumor microenvironment, while limiting their peripheral toxicity. Multivalent presentation of tumor-associated antigens on a targeted delivery system...
	Ethics for Bioengineers (Synthesis Lectures on Biomedical Engineering) by Monique Frize (Author) Increasingly, biomedical scientists and engineers are involved in projects, design, or research and development that involve humans or animals. The book presents general concepts on professionalism and the regulation of the profession of engineering, including a discussion on what is ethics and moral conduct, ethical theories and the codes of ethics that are most relevant for engineers. An ethical decision-making process is suggested. Other issues such as conflicts of interest, plagiarism, intellectual property, confidentiality, privacy, fraud, and corruption are presented. General guidelines, the process for obtaining ethics approval from Ethics Review Boards, and the importance of obtaining informed consent from volunteers recruited for studies are presented. A discussion on research...
	Bioengineer by Susan H. Gray (Author)
	Bioengineers make strides. (improvement of fruits and vegetables)(Foods of Tomorrow): An article from: Food Processing by Frances Katz (Author) This digital document is an article from Food Processing, published by Putman Media, Inc. on April 1, 1996. The length of the article is 1578 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the supplier: Bioengineering is slowly becoming a widely-practised method among plant breeders as more and more people become conscious of nutrients, freshness, phytochemicals and nutrients in fruits and vegetables. Plant products that are developed along non-traditional lines are crunchier, more flavorful, more eye-pleasing and more nutritious. Bioengineering can also produce plant products that are more...
	Science Digest Magazine (Mind Games , Bioengineers , Brain Chemistry of a KIller, January 1983) by The New Shuttle Fleet (Introduction)
	Circuits, Signals, and Systems for Bioengineers: A MATLAB-Based Introduction (Biomedical Engineering) by John L. Semmlow (Author)
	Signals and Systems for Bioengineers, Second Edition: A MATLAB-Based Introduction (Biomedical Engine [Hardcover] by John Semmlow (Author)
	Circuits, Signals and Systems for Bioengineers: **Replacement CD** (Biomedical Engineering) by John Semmlow (Author)